MELIOR DISCOVERY, INC.

MELIOR DISCOVERY, INC. is a contract research organization (CRO) for non-clinical studies that has been serving the pharmaceutical industry since 2005.in vivo(in vivo) pharmacological testing services.

This section details the features of MELIOR DISCOVERY, INC. 's non-clinical studies, an example of a pathological model, and case studies.

Features of MELIOR DISCOVERY, INC. 's Contract Nonclinical Trial Services

Phenotypic screening platform

We have the company's screening platforms, theraTRACE and opioidTRACE, to systematically identify new therapeutic potential for compounds. These platforms enable rapid and cost-effective screening for drug repurposing and discovery of new indications.

(as adjectival phrase) wide-rangingin vivoProvision of animal models

The company has more than 150 validated animal models using rats and mice, covering a wide range of 14 therapeutic areas. It offers modifications of existing models, reproduction of models based on literature, and customization options.

We are able to conduct studies and acquire data at an early stage in accordance with the client's drug development program.

An example of MELIOR DISCOVERY, INC. 's pathological model

Metabolic disease model

MELIOR DISCOVERY, INC. offers a wide range of products for various therapeutic areas.in vivoWe have an assortment of disease models. As an example, we have animal models of metabolic diseases (Metabolic). This allows us to evaluate the efficacy of new drug candidate compounds appropriate to the client's development objectives and to conduct customized studies according to the client's needs.

Neurological disease and pain models

The company also has numerous disease models for Neurology, Pain, Aging, and Inflammation & Arthritis. These diverse disease models are used to screen compounds and provide data to accelerate preclinical drug development programs.

MELIOR DISCOVERY, INC. 's Non-clinical Case Studies

Using a brain tumor modelin vivotest

For Modifi Bio, a cancer drug developer, MELIOR DISCOVERY, INC. requires advanced technology using intracranial (orthotopic) and subcutaneous transplantation of tumor cells into the brain.in vivoDrug efficacy studies. Through comparative studies of in-house developed and control drugs, the company provided data, including survival curves and luminescence imaging, in less than one week. The visual and compelling results earned investor confidence and significantly advanced the company's funding and R&D efforts.

Special Order to Accelerate Progress in Gene Therapyin vivoModels and rapid data delivery

Replay Bio's HSV vector custom-made for gene therapyin vivoModels were developed to evaluate vector expression over time, and we responded by quickly providing data on day 7 of the start of the 30-day study, resulting in early improvements to the vector design. As a result, critical data showing long-term durability was delivered in a matter of days, contributing significantly to winning recognition from investors and accelerating development.

MELIOR DISCOVERY, INC. Company Information

MELIOR DISCOVERY, INC. is a Pennsylvania, USA based contract non-clinical testing organization. It has completed thousands of studies and evaluated hundreds of compounds.